MoneyWorks4Me

Samrat Pharmachem informs about compliance certificate

21 Nov 2018 Evaluate

In pursuance of Regulation 40(9), (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Samrat Pharmachem has informed about Compliance Certificate received from Practising Company Secretary regarding transfer of shares for the half year ended on 30th September, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..